Alx Oncology Holdings 

Quarterly Financials

Values in thousands 2024-06-30 2024-03-31 2023-12-31
Revenue
$0
$0
$2,480
Gross Profit
-220
-214
2,273
EBITDA
-38,750
-34,940
-44,850
EBIT
-38,970
-35,154
-45,057
Net Income
-39,399
-35,581
-45,472
Net Change In Cash
0
0
2,480
Free Cash Flow
-26,656
-38,072
-39,826
Cash
15,534
14,041
22,406
Basic Shares
51,831
50,120
48,995

Annual Financials

Values in thousands 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Revenue
$0
$0
$0
$1,182
Gross Profit
-836
-1,466
-736
107
EBITDA
-158,404
-127,094
-83,471
-43,461
EBIT
-159,240
-127,436
-84,207
-43,663
Net Income
-160,805
-123,482
-83,463
-45,740
Net Change In Cash
0
0
0
1,182
Cost of Revenue
-314,779
-70,552
425,202
Free Cash Flow
-131,638
-90,650
-73,024
-38,320
Cash
22,406
282,906
363,667
434,219
Basic Shares
42,987
40,699
40,308
39,844

Earnings Calls

Quarter EPS
2024-09-30
-$0.58
2024-06-30
-$0.76
2024-03-31
-$0.71
2023-12-31
-$0.93